Author

Pavel Trunecka 1

1 Institute for Clinical and Experimental Medicine,Transplantcentre,Prague,Czech Republic

ACUTE PANCREATITIS IN LIVER TRANSPLANT RECIPIENTS: INCIDENCE AND OUTCOME

Peter Macinga, Karel Poc, Pavel Trunecka, Julius Spicak, Tomas Hucl

DONOR TM6SF2 RS58542926 GENOTYPE IS AN INDEPENDENT RISK FACTOR FOR DEVELOPMENT OF STEATOSIS AFTER LIVER TRANSPLANTATION

Irena Hejlova, Magdalena Neroldova, Jaroslav Hubacek, Dana Dlouha, Libor Kolesar, M. Jirsa, Eva Honsova, Eva Sticova, Vera Lanska, Julius Spicak, Pavel Trunecka

INCIDENTAL HEPATOCELLULAR CARCINOMA: RISK FACTORS AND LONG-TERM OUTCOME AFTER LIVER TRANSPLANTATION

Renata Senkerikova, Sona Frankova, Jan Sperl, Martin Oliverius, Helena Filipova, Pavel Trunecka, Julius Spicak

NASH/FNALD: biopsy to whom and when?

Pavel Trunecka

OUTCOME OF LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS IN CONTEXT OF HLA-DR MISMATCH: SINGLE CENTRE EXPERIENCE

Pavel Drastich, Lukas Bajer, Antonij Slavcev, Marek Benes, Pavel Trunecka, Julius Spicak

PANCREATIC CYSTIC LESIONS IN LIVER TRANSPLANT RECIPIENTS: PREVALENCE AND OUTCOME

Peter Macinga, Dana Kautznerova, Jiri Fronek, Pavel Trunecka, Julius Spicak, Tomas Hucl

Recurrence of primary biliary cholangitis after liver transplantation: a single center experience

Pavel Drastich, Lukas Bajer, Klara Chmelova, Jan Březina, Peter Macinga, Eva Sticova, Pavel Trunecka, Pavel Taimr, Julius Spicak

RISK FACTORS FOR PRIMARY SCLEROSING CHOLANGITIS RECURRENCE AFTER LIVER TRANSPLANTATION

Lukas Bajer, Eva Sticova, Peter Macinga, Radim Janoušek, Pavel Trunecka, Julius Spicak, Pavel Drastich

Item 1 - 8 / 10
1